News and Announcements
OncoSil Medical Annual Report 2016
- Published September 16, 2016 11:29AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
12th September 2016, ASX Announcement
FY16 Achievements Delivered
September 2015
Submission of CE Mark application for OncoSil™
October 2015
OncoSil™ CE Mark application granted Fast Track review status
December 2015
Investigational Device Exemption (IDE) submitted to the U.S. FDA for OncoPac-1 clinical study
January 2016
Chris Roberts appointed Independent Non-Executive Director
February 2016
$10 million private placement to Regal Funds Management
March-April 2016
Q-Submissions meeting with FDA
Responses to CE Mark and FDA questions
May 2016
OncoSil Medical completes hiring of senior management for Leadership team
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
